GSK's blockbuster HIV drug linked with birth defects

GSK's blockbuster HIV drug linked with birth defects
- Regulators in Europe and the US have issued warnings about a link between GlaxoSmithKline's blockbuster HIV drug Tivicay (dolutegravir) and birth ...